> Tsumura and Dainippon Pharmaceutical have returned the development and marketing rights to the hypertension drug lercanidipine hydrochloride back to Italy's Recordati. Report > The FDA has announced ...
WASHINGTON, Jan. 25 (UPI) -- The U.S. Food and Drug Administration announced a recall Friday of all heparin and saline pre-filled flush syringes manufactured by AM2 PAT Inc. Two lots of the syringes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results